Study: Dual medications do not hasten recovery from depression
Taking two medications for depression does not hasten recovery from the condition that affects 19 million Americans each year, researchers at UT Southwestern Medical Center have found in a national study.
View ArticleOtsuka Pharmaceutical reports OPC-34712 Phase 2 trial results in major...
Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) today announced results from a Phase 2 clinical trial of OPC-34712, a novel D2 dopamine...
View ArticleFDA approves Mylan's ANDA for Venlafaxine HCl ER Capsules to treat...
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Venlafaxine...
View ArticleDr. Reddy’s launches generic ARICEPT, EFFEXOR XR and FEMARA in the US
Dr. Reddy's Laboratories today announced that it has launched three products in the US market.
View ArticleNew antidepressant prescription linked to increased risk of falls in nursing...
Nursing home residents taking certain antidepressant medications are at an increased risk of falling in the days following the start of a new prescription or a dose increase of their current drug,...
View ArticleNew generation antidepressants may increase risk of adverse outcomes in elderly
Older people taking new generation antidepressants are at more risk of dying or suffering from a range of serious health conditions including stroke, falls, fractures and epilepsy, a study involving...
View ArticleSwitching or adding antidepressants does not exacerbate side effects
Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the...
View ArticleNewer antidepressant decreases depression in Parkinson's patients without...
Certain antidepressants appear to decrease depression in people with Parkinson's disease without worsening motor problems, according to a study published in the April 11, 2012, online issue of...
View ArticleJanssen receives positive opinion from EMA CHMP for ZYTIGA to treat mCRPC
Janssen-Cilag International NV (Janssen) announced today that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted a positive opinion recommending...
View ArticleIQWiG completes first health economic evaluation
The German Institute for Quality and Efficiency in Health Care has completed its first health economic evaluation. The report on antidepressants published on 30 October 2013 shows that the "efficiency...
View ArticleEstrogen therapy and venlafaxine treatment effective for hot flashes, night...
A new research study from Brigham and Women's Hospital (BWH) that compares low-dose oral estrogen and low-dose non-hormonal venlafaxine hydrochloride extended release (XR) to placebo were both found...
View ArticleUnmet medication need in neuropathic pain
A systematic review and meta-analysis reveals that current treatments for neuropathic pain achieve only a moderate response in patients.
View ArticleJohns Hopkins researchers develop new strategies to treat depression in...
A multidisciplinary team of Johns Hopkins researchers has developed two new strategies to treat depression in young people using the selective serotonin reuptake inhibitor (SSRI) class of medications....
View ArticleNAMS panel provides recommendations to help women manage menopause-associated...
Some three-quarters of North American women have menopausal hot flashes, but many cannot use hormones for medical reasons or choose not to. Numerous products and techniques are promoted for hot...
View ArticleTwo-drug combination relieves depression in older adults
More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of...
View ArticleMulticenter trial compares popular treatments for menopause-related vaginal...
Hot flashes. Night sweats. These are the most common - or at least the most commonly talked about - symptoms of menopause. But one reality of The Change for many women is less discussed yet no less...
View ArticleNutritional supplements can enhance effectiveness of antidepressants
An international evidence review has found that certain nutritional supplements can increase the effectiveness of antidepressants for people with clinical depression.
View ArticleMost antidepressants are ineffective at treating children and teens, study shows
The majority of antidepressants prescribed to treat children and teenagers with major depression are ineffective and may even be unsafe, warn researchers.
View ArticlePersonal fish calculator reveals safety of seafood
Seafood is the main component of European Christmas menus. But with rising concern about chemical pollution in the marine environment, is seafood safe to eat?
View ArticleAntidepressant use during pregnancy could increase risk of birth defects in...
A new Université de Montréal study in the British Medical Journal reveals that antidepressants prescribed to pregnant women could increase the chance of having a baby with birth defects.
View Article
